Key result
Low Lp(a) levels linked to reduced lung function with up to ~217 mL lower FEV1.
Why the study?
Relationships between cholesterol parameters including lipoprotein (a) and lung function have been controversial, with limited population-based data and no prior studies addressing Lp(a) at the population level.
Are lower Lipoprotein (a) levels associated with reduced pulmonary function in community-dwelling older people?
Cross-Sectional (n=606)
No
Are lower Lipoprotein (a) levels associated with reduced pulmonary function in community-dwelling older people?
In community-dwelling older adults, lower Lp(a) levels are paradoxically associated with worse pulmonary function, suggesting higher Lp(a) does not explain the increased CVD risk in people with reduced lung function.
Answers are grounded in this paper and cite their sources.
Higher Lp(a) linked to lung function warrants no clinical action; leaves open causal pathways in older community cohorts.
Reduced pulmonary function and elevated serum cholesterol levels are recognized risk factors for cardiovascular disease. Currently, there is some controversy concerning relationships between cholesterol, LDL-cholesterol, HDL-cholesterol, serum triglycerides and lung function. However, most previous studies compared patients suffering from chronic obstructive pulmonary disease (COPD) with healthy controls, and only a small number examined this relationship in population-based cohorts. Moreover, lipoprotein a [Lp(a)], another lipid parameter independently associated with cardiovascular diseases, appears not to have been addressed at all in studies of lung function at the population level. Here, we determined relationships between lung function and several lipid parameters including Lp(a) in 606 older community-dwelling participants (55.1% women, 68±4 years old) from the Berlin Aging Study II (BASE-II). We found a significantly lower forced expiration volume in 1 second (FEV1) in men with low Lp(a) concentrations (t-test). This finding was further substantiated by linear regression models adjusting for known covariates, showing that these associations are statistically significant in both men and women. According to the highest adjusted model, men and women with Lp(a) levels below the 20th percentile had 217.3ml and 124.2ml less FEV1 and 239.0ml and 135.2ml less FVC, respectively, compared to participants with higher Lp(a) levels. The adjusted models also suggest that the known strong correlation between pro-inflammatory parameters and lung function has only a marginal impact on the Lp(a)-pulmonary function association. Our results do not support the hypothesis that higher Lp(a) levels are responsible for the increased CVD risk in people with reduced lung function, at least not in the group of community-dwelling older people studied here.
No takes yet. Share an insight, caveat, or question.
Buchmann et al. (2015) conducted a cross-sectional in Community-dwelling older people (n=606). Low Lipoprotein (a) levels (<20th percentile) vs. Higher Lipoprotein (a) levels (≥20th percentile) was evaluated on Forced expiratory volume in 1 second (FEV1) (MD -217.3 ml (men) and -124.2 ml (women), p=<0.05). Men and women with Lipoprotein (a) levels below the 20th percentile had lower FEV1 compared to participants with higher Lp(a) levels.
Synapse has enriched 10 related papers. Consider them for comparative context: